Bristol-Myers Squibb appoints Giovanni Caforio as chairman
Mr. Caforio has been chief executive officer of Bristol-Myers Squibb since May 2015 and has been serving on the company’s Board of Directors since June 2014.
Prior to becoming CEO, Mr. Caforio served as chief operating officer with responsibility for leading a fully integrated worldwide commercial organization and the companywide functions of Enterprise Services and Global Manufacturing & Supply.
This was preceded by his work as the company’s chief commercial officer.
Mr. Caforio received his M.D. from the University of Rome.
Mr. Caforio, who will continue to serve as chief executive officer, will succeed current Chairman Lamberto Andreotti, who has announced his plan to retire.
Mr. Andreotti served as Bristol-Myers Squibb’s chief executive officer from 2010 through May 2015 and will have served as Bristol-Myers Squibb’s chairman for two years when Caforio’s appointment becomes effective in May 2017. ■
What to read next
LATEST MOVES FROM New York
- Coty appoints Sabine Chalmers to board
- Revlon appoints Christopher Peterson as COO
- CIT Group appoints John Fawcett as CFO
- PAR Technology appoints Donald H. Foley as CEO
- Manning & Napier appoints Kenneth Marvald to board
More inside POST
ZTE swings to 2016 loss on U.S. fine Earnings